• Home
  •  / Thermo Fisher Scientific

Thermo Fisher Scientific

OverviewSuggest Edit

Thermo Fisher Scientific is a global provider of laboratory products and services, life science solutions, analytical instruments, and specialty diagnostics. It operates through 4 segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease. The Analytical Instruments segment provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment delivers diagnostic test kits, reagents, culture media, instruments, and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products as well as outsourced services used by the pharmaceutical and biotech industries for drug development, clinical trials logistics, and commercial drug manufacturing.
TypePublic
Founded1956
HQWaltham, USMap
Websitethermofisher.com
View Jobs (3,236)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)75,000(+8%)
Job Openings3,236
Revenue (FY, 2019)$25.5 B(+5%)
Share Price (Oct 2020)$461.3 (-1%)
Cybersecurity ratingCMore

Key People/Management at Thermo Fisher Scientific

Marc N. Casper

Marc N. Casper

Chairman, President and Chief Executive Officer
Michael A. Boxer

Michael A. Boxer

Senior Vice President and General Counsel
Lisa P. Britt

Lisa P. Britt

Senior Vice President, Chief Human Resources Officer
Tom Grover

Tom Grover

Vice President, Financial Operations
Mark P. Stevenson

Mark P. Stevenson

Executive Vice President and Chief Operating Officer
Shiraz Ladiwala

Shiraz Ladiwala

Senior Vice President, Intergrations
Show more

Thermo Fisher Scientific Office Locations

Thermo Fisher Scientific has offices in Waltham, Agawam, Allentown, Ann Arbor and in 351 other locations
Waltham, US (HQ)
168 3rd Ave
Agawam, US
325 Bowles Rd
Allentown, US
7554 Schantz Rd
Ann Arbor, US
110 Miller Ave
Asheville, US
275 Aiken Rd
Auburn, US
2039 McMillan St
Show all (439)

Thermo Fisher Scientific Financials and Metrics

Thermo Fisher Scientific Revenue

Embed Graph
View revenue for all periods
Thermo Fisher Scientific's revenue was reported to be $25.54 b in FY, 2019 which is a 4.9% increase from the previous period.
USD

Revenue (Q2, 2020)

6.9b

Gross profit (Q2, 2020)

3.5b

Gross profit margin (Q2, 2020), %

50.6%

Net income (Q2, 2020)

1.2b

EBIT (Q2, 2020)

1.4b

Market capitalization (19-Oct-2020)

182.5b

Closing stock price (19-Oct-2020)

461.3

Cash (27-Jun-2020)

5.8b

EV

198.0b
Thermo Fisher Scientific's current market capitalization is $182.5 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

20.9b24.4b25.5b

Revenue growth, %

14%16%5%

Cost of goods sold

11.5b13.5b14.2b

Gross profit

9.4b10.9b11.3b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

5.9b6.1b5.9b6.1b6.3b6.3b6.2b6.9b

Cost of goods sold

3.3b3.3b3.3b2.4b3.5b3.5b3.5b3.4b

Gross profit

2.6b2.7b2.6b3.7b2.8b2.8b2.7b3.5b

Gross profit Margin, %

44%45%44%61%45%44%44%51%
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

1.3b2.1b2.4b

Accounts Receivable

3.9b4.1b4.3b

Inventories

3.0b3.0b3.4b

Current Assets

9.4b10.6b11.9b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

950.0m937.0m1.1b1.1b2.3b1.3b3.0b5.8b

Accounts Receivable

4.0b3.9b3.9b4.2b4.1b4.4b4.5b4.5b

Inventories

2.9b2.9b3.0b3.1b3.2b3.3b3.5b3.6b

Current Assets

9.6b9.5b9.6b9.9b11.2b10.5b12.7b15.8b
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

2.2b2.9b3.7b

Depreciation and Amortization

2.0b2.3b2.3b

Inventories

(81.0m)(324.0m)(458.0m)

Accounts Payable

274.0m201.0m266.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

579.0m1.3b2.0b815.0m1.9b2.7b788.0m1.9b

Depreciation and Amortization

575.0m1.1b1.7b555.0m1.1b1.7b574.0m1.1b

Inventories

(124.0m)(195.0m)(333.0m)(140.0m)(273.0m)(449.0m)(141.0m)

Accounts Payable

(94.0m)(20.0m)(45.0m)(129.0m)(202.0m)70.0m(241.0m)
show all
USDFY, 2017

EV/EBIT

32.3 x

EV/CFO

23.9 x

Revenue/Employee

298.8k

Debt/Equity

0.8 x

Debt/Assets

0.4 x

Financial Leverage

2.2 x

P/E Ratio

33.9
Show all financial metrics

Thermo Fisher Scientific Operating Metrics

Thermo Fisher Scientific's Customers was reported to be 400 k in FY, 2019.
FY, 2016FY, 2017FY, 2018FY, 2019Mar, 2020

Brands

6

Customers

400 k400 k400 k400 k
Show all operating metrics

Thermo Fisher Scientific Acquisitions / Subsidiaries

Company NameDateDeal Size
QiagenMarch 03, 2020$11.50 b
Brammer BioJune 17, 2019
HighChemJune 06, 2019
Gatan IncJune 29, 2018$925 m
PatheonAugust 29, 2017$7.20 b
Core InformaticsMarch 07, 2017
236 Perinton Parkway, LLC
27 Forge Parkway LLC
Abgene Inc.
Abgene Limited
Show more

Thermo Fisher Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

C

72/100

Learn more about about our premium products
SecurityScorecard logo

Thermo Fisher Scientific Revenue Breakdown

Embed Graph

Thermo Fisher Scientific revenue breakdown by business segment: 39.7% from Laboratory Products and Services, 13.9% from Specialty Diagnostics, 20.7% from Analytical Instruments and 25.7% from Life Sciences Solutions

Thermo Fisher Scientific revenue breakdown by geographic segment: 10.8% from China, 48.4% from United States and 40.8% from Other

Thermo Fisher Scientific Online and Social Media Presence

Thermo Fisher Scientific's Trends

Embed Graph

Thermo Fisher Scientific News and Updates

November 08, 2020

Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.19 per share. The dividend will be paid on January 15, 2020, to shareholders of record as of December 17, 2019.
October 20, 2020

Global Influenza Diagnostics Market Report 2020 Featuring Alere, Analytik Jena, BD and Co, DiaSorin, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, Quidel, SA Scientific, Thermo Fisher Scientific

DUBLIN, Oct. 20, 2020 /PRNewswire/ -- The "Influenza Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Influenza Diagnostics estimated at US$2.5 Billion in the year 2020, is...
October 15, 2020

Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing

CARLSBAD, Calif., Oct. 15, 2020 /PRNewswire/ -- Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The...
October 12, 2020

Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests

These new tests for detecting COVID-19 antibodies expand the company's leading response to the pandemic, which ranges from molecular diagnostic tests and sample collection products, to personal protective equipment, to support of therapy and vaccine development and manufacturing.read more
September 29, 2020

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

Program will leverage Ion Torrent Genexus System* and Oncomine Precision Assay* to advance precision medicine for lung cancer in Asia.read more
September 25, 2020

CRISPR Technology 2020 Global Market Key Players – Thermo Fisher Scientific, Merck KGaA, GenScript, Cellecta - Analysis and Forecast to 2026

Wiseguyreports.Com Publish New Market Research Report On-“CRISPR Technology Market 2020 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2026” Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

 Thermo Fisher Scientific Frequently Asked Questions

  • When was Thermo Fisher Scientific founded?

    Thermo Fisher Scientific was founded in 1956.

  • Who are Thermo Fisher Scientific key executives?

    Thermo Fisher Scientific's key executives are Marc N. Casper, Michael A. Boxer and Lisa P. Britt.

  • How many employees does Thermo Fisher Scientific have?

    Thermo Fisher Scientific has 75,000 employees.

  • What is Thermo Fisher Scientific revenue?

    Latest Thermo Fisher Scientific annual revenue is $25.5 b.

  • What is Thermo Fisher Scientific revenue per employee?

    Latest Thermo Fisher Scientific revenue per employee is $340.6 k.

  • Who are Thermo Fisher Scientific competitors?

    Competitors of Thermo Fisher Scientific include Bruker, Avantor and Bio-Rad.

  • Where is Thermo Fisher Scientific headquarters?

    Thermo Fisher Scientific headquarters is located at 168 3rd Ave, Waltham.

  • Where are Thermo Fisher Scientific offices?

    Thermo Fisher Scientific has offices in Waltham, Agawam, Allentown, Ann Arbor and in 351 other locations.

  • How many offices does Thermo Fisher Scientific have?

    Thermo Fisher Scientific has 439 offices.